KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Borsa Italiana Milan - NL0000009538 - Common Stock - Currency: EUR
Overall 1PHIA gets a fundamental rating of 3 out of 10. We evaluated 1PHIA against 55 industry peers in the Health Care Equipment & Supplies industry. 1PHIA may be in some trouble as it scores bad on both profitability and health. 1PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
1PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
Of the past 5 years 1PHIA 4 years had a positive operating cash flow.
1.2 Ratios
1PHIA's Return On Assets of -1.43% is in line compared to the rest of the industry. 1PHIA outperforms 41.18% of its industry peers.
With a Return On Equity value of -3.54%, 1PHIA perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of 1PHIA has declined.
1PHIA's Gross Margin of 41.56% is on the low side compared to the rest of the industry. 1PHIA is outperformed by 68.63% of its industry peers.
1PHIA's Gross Margin has been stable in the last couple of years.
1PHIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
1PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1PHIA has less shares outstanding
The number of shares outstanding for 1PHIA has been increased compared to 5 years ago.
The debt/assets ratio for 1PHIA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.62, we must say that 1PHIA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of 1PHIA (1.62) is comparable to the rest of the industry.
1PHIA has a debt to FCF ratio of 7.27. This is a slightly negative value and a sign of low solvency as 1PHIA would need 7.27 years to pay back of all of its debts.
1PHIA has a Debt to FCF ratio (7.27) which is comparable to the rest of the industry.
1PHIA has a Debt/Equity ratio of 0.60. This is a neutral value indicating 1PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, 1PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.62 |
ROIC/WACCN/A
WACC6.01%
2.3 Liquidity
1PHIA has a Current Ratio of 1.16. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, 1PHIA is doing worse than 72.55% of the companies in the same industry.
1PHIA has a Quick Ratio of 1.16. This is a bad value and indicates that 1PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1PHIA (0.74) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.65% over the past year.
Measured over the past years, 1PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
The Revenue has decreased by -2.65% in the past year.
Measured over the past years, 1PHIA shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
3.2 Future
The Earnings Per Share is expected to grow by 17.22% on average over the next years. This is quite good.
1PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y17.22%
Revenue Next Year-1.8%
Revenue Next 2Y1.14%
Revenue Next 3Y2.28%
Revenue Next 5Y3.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.42 indicates a rather expensive valuation of 1PHIA.
1PHIA's Price/Earnings ratio is rather cheap when compared to the industry. 1PHIA is cheaper than 82.35% of the companies in the same industry.
1PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 28.64, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.97, 1PHIA is valued correctly.
1PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1PHIA is cheaper than 78.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.51, 1PHIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.42 | ||
| Fwd PE | 14.97 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1PHIA.
1PHIA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1PHIA is cheaper than 86.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.71 | ||
| EV/EBITDA | 30.17 |
4.3 Compensation for Growth
1PHIA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1PHIA's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y16.17%
EPS Next 3Y15.06%
5. Dividend
5.1 Amount
1PHIA has a Yearly Dividend Yield of 4.15%, which is a nice return.
1PHIA's Dividend Yield is rather good when compared to the industry average which is at 2.50. 1PHIA pays more dividend than 96.08% of the companies in the same industry.
1PHIA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of 1PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1PHIA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-0.48%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
KONINKLIJKE PHILIPS NV
BIT:1PHIA (1/13/2025, 7:00:00 PM)
25.05
-0.26 (-1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.12%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.55B
Analysts71.85
Price Target28.75 (14.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Yearly Dividend0
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)-3.81%
PT rev (3m)0.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-2.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.42 | ||
| Fwd PE | 14.97 | ||
| P/S | 1.3 | ||
| P/FCF | 20.71 | ||
| P/OCF | 13.08 | ||
| P/B | 1.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 30.17 |
EPS(TTM)1.29
EY5.15%
EPS(NY)1.67
Fwd EY6.68%
FCF(TTM)1.21
FCFY4.83%
OCF(TTM)1.92
OCFY7.64%
SpS19.29
BVpS12.64
TBVpS-1.53
PEG (NY)0.95
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM | 6.27% |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 181.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 1.62 |
F-Score5
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y17.22%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-1.8%
Revenue Next 2Y1.14%
Revenue Next 3Y2.28%
Revenue Next 5Y3.86%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%